AI Patient Monitoring Market

Overview

The global AI Patient Monitoring Market was valued at USD 3.1 billion in 2025 and is projected to reach USD 21.2 billion by 2034, growing at a CAGR of 24.0% during the forecast period (2026–2034). The market is driven by acute staffing gaps in hospitals, the need to detect patient deterioration earlier than periodic spot checks allow, and the steady move of higher-acuity care into the home. The market is shifting from conventional, threshold-based alarms and periodic vital sign checks toward continuous, predictive and interoperable monitoring. Older systems raised an alarm whenever a single value crossed a limit, which created alarm fatigue and left gaps between checks. Government initiatives such as the US Food and Drug Administration's total product lifecycle oversight and predetermined change control plans for AI-enabled medical devices, the European Union Medical Device Regulation (EU) 2017/745, which now governs CE marking of AI monitoring software, and India's BIRAC support for health technology start-ups are shaping how products are validated, updated and launched across major markets. By region, North America held the largest share of the market in 2025 at 42%, supported by broad hospital adoption of continuous monitoring platforms, the presence of leading vendors and a large base of FDA-cleared AI devices. Asia-Pacific is expected to be the fastest-growing region during the forecast period, driven by large hospital capacity, government-backed innovation in India and China, and domestic manufacturers scaling AI-enabled monitors.

Market Size & Share

Market Dynamics

KEY MARKET TREND

Shift from Threshold Alarms to Predictive and Interoperable Monitoring Emerging as a Transformational Trend

• Hospitals are replacing single-value alarm limits with models that read trends across heart rate, respiration, blood pressure and temperature. Mindray's Early Insight Assistant, built from an interpretable early warning model published in npj Digital Medicine, runs directly on existing BeneVision V Series ICU monitors, so deterioration alerts arrive without extra infrastructure.
• Waveform-level data is becoming the raw material for hospital AI. Sickbay from Medical Informatics Corp collects time-series waveforms from devices of different vendors at native resolution, while GE HealthCare designed Portrait Mobile around IHE and HL7 standards so that admit-discharge-transfer events and clinical documentation flow into EMR systems without custom interfaces.
• Ambient sensing is widening the definition of monitoring beyond wearables. Dozee's under-mattress sensor uses ballistocardiography and AI to derive heart rate, respiration and blood pressure without touching the patient, and Stryker's care.ai adds camera and sensor-based room monitoring to virtual nursing stations, which pushes traditional monitor makers toward contactless and ambient options.
• Philips announced new collaborations with Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree and smartQare. The agreements extend its open monitoring ecosystem from the bedside to wearable and hospital-at-home settings, with continuous patient data flowing into the Patient Information Center iX platform for clinicians to review.

KEY MARKET DRIVER

Rising Clinician Workload and Demand for Early Detection of Patient Deterioration Driving Market Growth

• Periodic spot checks leave long gaps in observation, because vital signs on general wards are commonly recorded only every four to six hours. Continuous monitoring with AI trend analysis narrows those gaps by flagging gradual shifts in respiration rate, oxygen saturation and pulse rate before a patient needs a rapid response call or an unplanned ICU transfer.
• Nursing shortages are pushing hospitals to automate observation and cut nuisance alarms. Philips reports up to a 40% reduction in non-actionable ICU alarms at St Antonius Hospital, and Dozee states that its contactless system saves nearly 2.5 hours of nursing time per patient each day, which frees scarce staff for patients that algorithms rank as highest risk.
• Peer-reviewed evidence is strengthening purchase cases. BioIntelliSense announced a 15-month observational study in the Journal of Clinical Medicine covering 11,977 hospitalized floor patients in two US hospitals, which linked continuous wireless vital sign monitoring with algorithm-based analytics to earlier detection of deterioration and gives finance teams data to support wider rollouts.
• The US Centers for Medicare and Medicaid Services finalized its CY 2026 Physician Fee, effective 1 January 2026. The rule added CPT 99445 for device supply over 2 to 15 days and CPT 99470 for 10 to 100 minutes of monthly management, allowing providers to bill for shorter remote monitoring episodes.

KEY MARKET OPPORTUNITY

Expansion of Ambient Intelligence and Virtual Nursing Creating New Revenue Streams

• Home and post-acute settings remain lightly monitored compared with hospital wards. Vivalink packages wearable ECG, temperature, oxygen saturation and blood pressure sensors with a biometrics data platform for hospital-at-home and ambulatory cardiac monitoring, giving health systems a route to extend continuous observation to patients who leave the building but still carry clinical risk.
• New commercial models are lowering the upfront cost of AI monitoring. BioIntelliSense sells a medical-grade Data-as-a-Service platform and Medical Informatics Corp describes Sickbay as real-time clinical surveillance-as-a-service, so hospitals can pay for continuous data and analytics on a subscription basis, which widens access for mid-sized and community hospitals with limited capital budgets.
• Emerging markets offer patient volume that mature markets cannot match. Dozee reports deployments in more than 280 hospitals across India, the United States and Africa, and it raised USD 8.3 million in equity and debt led by Temasek Trust's C3H and Stockhausen International to fund global expansion and research, which shows investor appetite for locally developed AI monitoring.
• Artisight announced an agreement with UChicago Medicine to deploy its Smart Hospital Platform for virtual nursing, virtual sitting, bedside TV engagement, infusion monitoring and Smart OR capabilities. All applications run on one shared sensor fabric, which replaces separate point solutions and lets one health system manage several care settings from a single platform.

AI Patient Monitoring Market Size, 2025-2034 (USD Billion)

Segmentation Analysis

Analysis by Component

Hardware held the largest market share in 2025 because hospitals still buy AI monitoring capability as part of physical devices such as bedside monitors, telemetry units and wearable sensors that carry the algorithms inside them. Masimo's Radical-7 combines bedside, handheld and transport monitoring in one device, GE HealthCare's Portrait Mobile pairs wearable sensors with a smartphone-sized monitor that tracks respiration rate, oxygen saturation and pulse rate continuously, and Philips launched a touchscreen smart telemetry platform in September 2025. Regular replacement cycles for monitors keep hardware orders steady and bring AI features into every new installation.

Software is projected to grow at the fastest CAGR during the forecast period, because hospitals want algorithms and analytics that work across the devices they already own instead of replacing every monitor. Nihon Kohden's CoMET tool applies models trained on more than 100 terabytes of monitoring and waveform data to rank patients by predicted risk of severe illness and to show trajectories of deterioration and recovery. Subscription pricing and frequent model updates give vendors recurring revenue and give hospitals a lower entry cost than a full monitor refresh, which favors software over new equipment.

Component categories include

• Hardware (Dominating Segment)
• Software (Highest CAGR Segment)
• Services

Analysis by Technology

Machine learning, which includes deep learning models, held the largest market share in 2025 because most cleared monitoring algorithms are trained on structured vital sign, waveform and laboratory data, where these methods perform best. The Acumen Hypotension Prediction Index was built from more than 200,000 patient events and estimates the likelihood of low blood pressure before it occurs, while iRhythm's deep-learned algorithm classifies 13 arrhythmia classes using more than two billion hours of curated heartbeat data. Large retrospective hospital datasets give machine learning developers a proven route to regulatory submission.

Computer vision is projected to grow at the fastest CAGR during the forecast period, as hospitals look for ways to watch patients without adding wires or nurses to the room. Artisight's platform combines AI-enabled cameras, voice sensors and edge processing to detect when at-risk patients try to leave bed and to alert care teams automatically. Virtual nursing programs are creating steady demand because one remote nurse can observe many rooms through the same camera network, and vendors can spread hardware cost across fall alerts, documentation and monitoring on one sensor layer.

Technology categories include

• Machine Learning (Dominating Segment)
• Computer Vision (Highest CAGR Segment)
• Natural Language Processing
• Others

Analysis by Deployment

Cloud-based deployment held the largest market share in 2025 because it lets vendors update algorithms centrally and lets health systems scale monitoring across sites and homes without buying new servers. BioIntelliSense delivers vital sign data through its BioCloud data services and BioDashboard clinical intelligence system, and Dozee's cloud-enabled early warning system gives central and remote monitoring views for non-ICU wards. Cloud analytics also suit remote patient monitoring, where data from wearables must reach clinicians outside the hospital network in near real time, and vendor-managed updates reduce the burden on hospital IT teams.

Hybrid deployment is projected to grow at the fastest CAGR during the forecast period, as hospitals want raw waveform data processed locally while analytics and model updates arrive from the cloud. Medical Informatics Corp's Sickbay is offered on Cisco Unified Edge, where one compute node supports data acquisition for 500 beds and processes signals near the bedside to cut latency. Artisight performs on-device processing to protect privacy and limit bandwidth use while documenting events in Epic flowsheets. These designs keep high-frequency data inside the hospital and still allow enterprise dashboards.

Deployment categories include

• Cloud-Based (Dominating Segment)
• Hybrid (Highest CAGR Segment)
• On-Premises

Analysis by Application

Cardiovascular monitoring held the largest market share in 2025 because heart rhythm, blood pressure and hemodynamic data are the best-structured signals for AI, and cleared algorithms already exist for each of them. iRhythm's Zio service records up to 14 days of continuous ECG and has produced more than 12 million patient reports, AliveCor's handheld Kardia 12L uses AI to detect life-threatening conditions such as heart attacks with a reduced lead set, and Philips Mobile Cardiac Telemetry lets clinicians follow suitable patients for up to 30 days after an inpatient or emergency department evaluation.

Sepsis monitoring is projected to grow at the fastest CAGR during the forecast period, as hospitals look for ways to recognize infection-related deterioration hours before criteria are formally met. The Centers for Medicare and Medicaid Services keeps sepsis care under quality reporting through its SEP-1 bundle measure, which gives hospital quality teams a direct reason to invest in earlier detection. Mindray offers SepsisSight as a clinical assistive application on its BeneVision N Series monitors to guide clinicians at the bedside, and vendors are extending temperature, heart rate and respiration trend models from intensive care units to general wards.

Application categories include

• Cardiovascular Monitoring (Dominating Segment)
• Sepsis Monitoring (Highest CAGR Segment)
• Respiratory Monitoring
• Neurological Monitoring
• Fall Prevention Monitoring

Analysis by End User

Hospitals held the largest market share in 2025 because acute care units generate the highest volume of monitored patients, control the capital budgets for monitors and analytics, and face the strongest pressure to prevent avoidable ICU transfers. Masimo reports that Dartmouth-Hitchcock reduced unplanned ICU transfers by 50% and rescue events by 60% after deploying Patient SafetyNet, a Bengaluru hospital reports an 88% drop in Code Blue events with Dozee, and Stryker positions Vocera and care.ai together as the base of its SmartHospital platform for enterprise-wide deployment. Hospitals also hold the reimbursement, IT staff and clinical governance needed to validate new algorithms.

Home care settings are projected to grow at the fastest CAGR during the forecast period, because health systems are moving higher-acuity care out of hospital buildings and need monitoring that keeps clinicians informed after discharge. BioIntelliSense's rechargeable BioButton multi-patient wearable extends continuous vital sign collection to a patient's own residence and supports hospital-level care at home. Wearables that transmit through gateways and smartphones reduce what patients must operate themselves, which matters for older adults, and remote monitoring lets hospitals release inpatient beds sooner while keeping discharged patients under clinical watch, which reduces the risk of readmission.

End User categories include

• Hospitals (Dominating Segment)
• Home Care Settings (Highest CAGR Segment)
• Ambulatory Care Centers
• Long-Term Care Facilities

By Region

AI Patient Monitoring Market Share 2025, (CAGR)

North America

42%

South America

xx%

Europe

24%

Middle East Africa

xx%

Asia Pacific

xx%

North America held the largest market share in 2025, accounting for 42% of global revenue, supported by early adoption of continuous monitoring in hospitals and a dense base of technology vendors. In the United States, health systems are expanding deployments across whole facilities, such as Houston Methodist's inpatient expansion of BioIntelliSense's BioButton solution, while startups including Artisight, AliveCor and Medical Informatics Corp commercialize FDA-cleared or AI-enabled products. FDA 510(k), De Novo and premarket approval pathways give buyers a clear validation route. Canada adopts AI monitoring through provincially funded hospital networks under Health Canada device licensing, while Mexico is at an earlier stage of adoption.

Asia-Pacific is projected to grow at the fastest CAGR during the forecast period, rising from a 22% share in 2025 to about 33% by 2034 as governments and hospital groups invest in workforce-saving technology. In China, Mindray's BeneVision central monitoring system connects up to 1,200 devices across a hospital enterprise. India is the fastest-growing country market, where Dozee's contactless AI monitoring, supported by BIRAC, is deployed in hospitals across the country. Japan is anchored by Nihon Kohden, whose CoMET tool ranks patients by predicted risk, while South Korea benefits from VUNO's deep-learning pediatric early warning system, validated across several hospitals.

Countries and Regions Covered

Asia-Pacific (Fastest Growing Region)

• China (Largest Country Market)
• India (Fastest-Growing Country Market)
• Japan
• South Korea
• Rest of Asia-Pacific

North America (Dominating Region)

• United States (Largest Country Market)
• Canada
• Mexico

Europe

• Germany (Largest Country Market)
• France
• United Kingdom
• Italy
• Rest of Europe

Latin America

• Brazil (Largest Country Market)
• Chile (Fastest-Growing Country Market)
• Rest of Latin America

Middle East & Africa

• Saudi Arabia (Largest Country Market)
• United Arab Emirates (Fastest-Growing Country Market)
• Rest of Middle East & Africa

Market Share

The AI Patient Monitoring Market is consolidated. Established monitor manufacturers such as Philips, GE HealthCare, Mindray, Nihon Kohden, Masimo and BD hold large hospital installed bases, while specialists including Medical Informatics Corp, Artisight, Dozee, iRhythm and AliveCor compete on algorithms, wearables and ambient sensing. Key success factors are FDA clearance or CE marking, integration with electronic health records, published clinical evidence and the ability to run across devices from several vendors. Leading companies are prioritizing open partner ecosystems, cloud and edge analytics, and expansion from the bedside into homes. Acquisitions shape the field: Stryker acquired care.ai in 2024, the Edwards critical care monitoring business became part of BD, and iRhythm licensed BioIntelliSense patents for ambulatory cardiac monitoring in 2024.

Key Players

• Royal Philips (Netherlands)
• GE HealthCare Technologies Inc. (US)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• Masimo Corporation (US)
• Becton, Dickinson and Company (US)
• Nihon Kohden Corporation (Japan)
• Stryker Corporation (US)
• iRhythm Technologies, Inc. (US)
• AliveCor, Inc. (US)
• Medical Informatics Corp. (US)
• Artisight, Inc. (US)
• Vivalink, Inc. (US)
• Dozee (India)

Recent Market Developments

• In April 2025, BD launched HemoSphere Alta, its next-generation hemodynamic monitoring platform, with Acumen Hypotension Prediction Index software and a new Cerebral Autoregulation Index that gives personalized blood pressure targets. The launch was the first major product release from BD's advanced patient monitoring business after it took over Edwards Lifesciences' critical care product group.
• In September 2025, Philips and Masimo renewed their multi-year strategic collaboration on patient monitoring, with a shared aim of accelerating next-generation monitoring solutions and widening access to Masimo's measurement technologies. The renewal keeps a major measurement technology supplier tied to one of the largest bedside monitor platforms.
• In October 2025, Hoag, Orange County's highest-ranked hospital, and Philips announced a 10-year strategic collaboration to unify patient monitoring across the Hoag network with scalable monitoring that adjusts to patient acuity and care setting. The agreement shows health systems moving to long-term enterprise monitoring partnerships.
• In January 2026, AliveCor received US FDA clearance for the next generation of KAI 12L, the AI behind its Kardia 12L handheld ECG system, adding five new determinations to reach 39. The clearance widens the range of rhythm and axis findings that AI can flag at the point of care.

Frequently Asked Questions

Key Questions Answered

Request a Sample

1

What is AI Patient Monitoring?

2

What is the CAGR of the AI Patient Monitoring Market?

3

Which component leads the AI Patient Monitoring Market?

4

Which end user dominates the AI Patient Monitoring Market?

5

Which technology has the highest market share?

6

What are the latest trends in the AI Patient Monitoring Market?

7

Who are the end users of AI Patient Monitoring?

Why Choose IG Transformation

Speak to Analyst

Strong Industry Focus

Extensive Product Offerings

Customer Research Services

Robust Research Methodology

Comprehensive Reports

Latest Technological Developments

Value Chain Analysis

Potential Market Opportunities

Growth Dynamics

Quality Assurance

Post-sales Support

Regular Report Updates